Login / Signup

Severe Autoimmune intravascular hemolytic anemia in patients receiving Alemtuzumab for Multiple sclerosis.

Parth SharmaAnnapurna SaksenaAdolfo Enrique DiazYifan PangParth Desai
Published in: Blood advances (2022)
Keyphrases
  • multiple sclerosis
  • chronic kidney disease
  • white matter
  • iron deficiency
  • coronary artery
  • early onset
  • drug induced